Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement

American Journal of Health-System Pharmacy

Volumn 65, Issue 19, 2008, Pages 1841-1845

  Anaya, Jaime P ^a   Rivera, Jose O ^b   Lawson, Ken ^b   Garcia, Jose ^c   Luna Jr , Jose ^c   Ortiz, Melchor ^d  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Centro Van Vicente   (United States)

^d School of Public Health   (United States)

Author keywords

Ambulatory care; Diabetes mellitus; Economics; Interventions; Pharmaceutical services; Pharmacists

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL PROTOCOL; COLLABORATIVE DRUG THERAPY AGREEMENT; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES MELLITUS; EMERGENCY HEALTH SERVICE; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEMOGLOBIN DETERMINATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACIST; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY;

EID: 54749114460     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070568     Document Type: Article

References (30)

1. Kaboli PJ, Hoth AB, McClimon BJ et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166:955-64.
2. American Society of Health-System Pharmacists. ASHP statement on the role of health-system pharmacists in public health. Am J Health-Syst Pharm. 2008; 65:462-7.
3. Cortelazzo S, Finazzi G, Viero P et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thrombosis Haemostasis. 1993; 69:316-20.
4. Garabedian-Ruffalo SM, Gray DR, Sax MJ et al. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm. 1985; 42:304-8.
5. Wilt VM, Gums JG, Ahmed OI et al. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy. 1995; 15:732-9.
6. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes and health care costs. Arch Intern Med. 1998; 158:1641-7.
7. Aubert RE, Herman WH, Waters J et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Int Med. 1998; 129:605-12.
8. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Earn Pract. 2001; 14:16-21.
9. West JA, Miller NH, Parker KM et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997; 79:58-63.
10. Rich MW, Beckham V, Wittenberg C et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333:1190-4.
11. Hammond RW, Schwartz AH, Campbell MJ et al. Collaborative drug therapy management by pharmacists - 2003. Pharmacotherapy. 2003; 23:1210-25.
12. Punekar Y, Lin SW, Thomas J. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice. J Am Pharm Assoc. 2003; 43:503-10.
13. Thomas J 3rd, Bharmal M, Lin SW et al. Survey of pharmacist collaborative drug therapy management in hospitals. Am J Health-Syst Pharm. 2006; 63:2489-99.
14. Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother. 2000; 34:772-87.
15. Centers for Medicare and Medicaid Services. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. www.cms.hhs.gov/MMAUpdate/downloads/ PL108-173summary.pdf (accessed 2007 Sep 11).
16. Farley JF, Devine JW, Hadsall RS. Professional implications of the expansion of pharmacy-based medical clinics. J Am Pharm Assoc. 2007; 47:410-5.
17. Scott DM, Boyd ST, Stephan M et al. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health-Syst Pharm. 2006; 63:2116-22.
18. Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007; 27:1040-51.
19. National Institute for Standards in Pharmacists Credentialing. www.nispcnet.org/(accessed 2007 Sep 11).
20. American Diabetes Association. Clinical practice recommendations. Diabetes Care. 2001; 24(suppl 1):S1-133.
21. U.S. Department of Labor. Bureau of Labor Statistics. Consumer price index for medical care. http://data.bls.gov/cgi-bin/surveymost (accessed 2007 Oct 1).
22. Coast-Senior EA, Kroner BA, Kelley CL et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998; 32:636-41.
23. Jaber LA, Halapy H, Fernet M et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996; 30:238-43.
24. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329:977-86.
25. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). U.K. Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:837-53. [Erratum, Lancet. 1999; 354:602.]
26. Khaw KT, Wareham N, Luben R et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001; 322:15-8.
27. Wagner EH, Sandhu N, Newton KM et al. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001; 285:182-9.
28. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998; 280:1490-6.
29. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003; 43:173-84.
30. De Lissovoy G, Ganaczy DA, Ray NF. Relationship of hemoglobin A1c, age of diabetes diagnosis, and ethnicity to clinical outcomes and medical costs in a computer-simulated cohort of persons with type 2 diabetes. Am J Managed Care. 2000; 6:573-84.